Literature DB >> 9934768

Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature.

H S Te1, T D Schiano, M Kahaleh, T W Lissoos, A L Baker, J Hart, H S Conjeevaram.   

Abstract

Malignant melanoma has a propensity to metastasize widely to many organs, involving the liver in up to one-third of cases. Fulminant hepatic failure is an unusual presentation of hepatic neoplasms, whether primary or metastatic. We describe a case of malignant melanoma with liver metastases that rapidly progressed to fulminant hepatic failure and death. Striking elevations of liver tests, particularly lactate dehydrogenase, were seen. Liver biopsy showed diffuse intrasinusoidal infiltration with melanoma cells. In patients with malignant melanoma, raised serum lactate dehydrogenase levels may suggest hepatic involvement, with extreme elevations possibly predictive of liver failure.

Entities:  

Mesh:

Year:  1999        PMID: 9934768     DOI: 10.1111/j.1572-0241.1999.00811.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  12 in total

Review 1.  Fulminant Hepatic Failure Secondary to Metastatic Transitional Cell Carcinoma-Case Report and Review of the Literature.

Authors:  Aijaz Ahmed Sofi; Luis de Las Casas; Zeeshan Tariq; Ali Nawras; Wael Youssef
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Metastatic breast cancer presenting as acute liver failure.

Authors:  Hector E Nazario; Rita Lepe; James F Trotter
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-01

3.  Malignant infiltration of the liver presenting as acute liver failure.

Authors:  Nicole E Rich; Corron Sanders; Randall S Hughes; Robert J Fontana; R Todd Stravitz; Oren Fix; Steven H Han; Willscott E Naugler; Atif Zaman; William M Lee
Journal:  Clin Gastroenterol Hepatol       Date:  2014-09-30       Impact factor: 11.382

4.  Acute hepatic failure secondary to extensive hepatic replacement by metastatic amelanotic melanoma: an autopsy case report.

Authors:  Takayuki Fusasaki; Ryoichi Narita; Masaaki Hiura; Shintaro Abe; Akinari Tabaru; Ryosuke Hino; Atsuji Matsuyama; Shohei Shimajiri; Yoshiki Tokura; Yasuyuki Sasaguri; Masaru Harada
Journal:  Clin J Gastroenterol       Date:  2010-10-23

5.  Tumor lysis syndrome and malignant melanoma.

Authors:  Meir Mouallem; Noa Zemer-Wassercug; Eitan Kugler; Nadav Sahar; Ronnie Shapira-Frommer; Ginette Schiby
Journal:  Med Oncol       Date:  2013-05-15       Impact factor: 3.064

6.  Hepatic encephalopathy associated with cancer or anticancer therapy.

Authors:  Kaspar J Willson; Louise M Nott; Vy T Broadbridge; Timothy Price
Journal:  Gastrointest Cancer Res       Date:  2013-01

Review 7.  Characterization of the syndrome of acute liver failure caused by metastases from breast carcinoma.

Authors:  Estela Mogrovejo; Palaniappan Manickam; Mitual Amin; Mitchell S Cappell
Journal:  Dig Dis Sci       Date:  2013-12-27       Impact factor: 3.199

8.  Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma.

Authors:  Gilaad G Kaplan; Shaun Medlicott; Bruce Culleton; Kevin B Laupland
Journal:  BMC Cancer       Date:  2005-06-30       Impact factor: 4.430

9.  Fulminant hepatic failure due to metastatic choroidal melanoma.

Authors:  Emmanuel Escobar-Valdivia; Roberto Monreal-Robles; Guillermo Delgado-García; Badir Hernández-Velazquez
Journal:  Caspian J Intern Med       Date:  2017

10.  Acute Warfarin Toxicity as Initial Manifestation of Metastatic Liver Disease.

Authors:  Varalaxmi Bhavani Nannaka; Nihar Jani; Masooma Niazi; Dmitry Lvovsky
Journal:  Case Rep Crit Care       Date:  2016-03-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.